LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIALWolfgang Wick, Martin J. van den Bent, Aa Brandes et al.|Neuro-Oncology|2015Cited by 79
Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)Antonino Musolino, Andrea Ardizzoni, Luigi Cavanna et al.|Cancer Research|2019Cited by 2
Abstract P1-13-02: WithdrawnValentina Guarneri, PierFranco Conte, Antonino Musolino et al.|Cancer Research|2018Cited by 0